Mirum Pharmaceuticals Inc (NASDAQ: MIRM) is 17.24% higher on its value in year-to-date trading and has touched a low of $23.14 and a high of $49.27 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The MIRM stock was last observed hovering at around $47.53 in the last trading session, with the day’s gains setting it 0.95%.
Currently trading at $48.48, the stock is 9.53% and 10.48% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.32 million and changing 2.00% at the moment leaves the stock 30.82% off its SMA200. MIRM registered 83.01% gain for a year compared to 6-month gain of 20.09%. The firm has a 50-day simple moving average (SMA 50) of $43.7453 and a 200-day simple moving average (SMA200) of $36.946823.
The stock witnessed a 16.18% loss in the last 1 month and extending the period to 3 months gives it a 26.18%, and is 3.26% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 4.34% over the week and 3.65% over the month.
Mirum Pharmaceuticals Inc (MIRM) has around 264 employees, a market worth around $2.33B and $307.03M in sales. Profit margin for the company is -31.69%. Distance from 52-week low is 109.51% and -1.60% from its 52-week high. The company has generated returns on investments over the last 12 months (-17.75%).
with sales reaching $96.64M over the same period.The EPS is expected to grow by 58.87% this year, but quarterly earnings will post 79.22% year-over-year. Quarterly sales are estimated to grow 38.95% in year-over-year returns.
Mirum Pharmaceuticals Inc (MIRM) Top Institutional Holders
263.0 institutions hold shares in Mirum Pharmaceuticals Inc (MIRM), with institutional investors hold 118.38% of the company’s shares. The shares outstanding are 47.97M, and float is at 38.31M with Short Float at 16.78%. Institutions hold 115.72% of the Float.
The top institutional shareholder in the company is FRAZIER LIFE SCIENCES MANAGEMENT, L.P. with over 6.5 million shares valued at $222.08 million. The investor’s holdings represent 13.8413% of the MIRM Shares outstanding. As of 2024-06-30, the second largest holder is JANUS HENDERSON GROUP PLC with 4.99 million shares valued at $170.56 million to account for 10.6307 of the shares outstanding. The other top investors are BVF INC/IL which holds 4.37 million shares representing 9.3123% and valued at over $149.41 million, while EVENTIDE ASSET MANAGEMENT, LLC holds 7.703 of the shares totaling 3.61 million with a market value of $123.59 million.
Mirum Pharmaceuticals Inc (MIRM) Insider Activity
The most recent transaction is an insider sale by Radovich Peter, the company’s PRESIDENT AND COO. SEC filings show that Radovich Peter sold 3,177 shares of the company’s common stock on Jan 24 ’25 at a price of $47.92 per share for a total of $0.15 million. Following the sale, the insider now owns 29588.0 shares.
Mirum Pharmaceuticals Inc disclosed in a document filed with the SEC on Jan 24 ’25 that Howe Jolanda (SVP, GLOBAL CONTROLLER) sold a total of 902 shares of the company’s common stock. The trade occurred on Jan 24 ’25 and was made at $47.92 per share for $43228.0. Following the transaction, the insider now directly holds 3524.0 shares of the MIRM stock.
Still, SEC filings show that on Jan 24 ’25, Peetz Christopher (CHIEF EXECUTIVE OFFICER) disposed off 6,837 shares at an average price of $47.92 for $0.33 million. The insider now directly holds 125,022 shares of Mirum Pharmaceuticals Inc (MIRM).
